Clinical Trial Detail

NCT ID NCT01956669
Title Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors GlaxoSmithKline
Indications

hepatoblastoma

osteosarcoma

neuroblastoma

Therapies

Pazopanib

Age Groups: child

No variant requirements are available.